Clinical Trial Update: Phase II Pilot Study of Fluconazole for Histoplasmosis, Blastomycosis, and Sporotrichosis [Phase 2]

View source ↗

Summary

Phase II pilot study evaluating fluconazole for histoplasmosis, sporotrichosis, and blastomycosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Blastomycosis
• Histoplasmosis
• Sporotrichosis

Drugs mentioned

• Fluconazole (Fluconazole)

Snippet

Sponsor: National Center for Research Resources (NCRR) | Conditions: Histoplasmosis, Sporotrichosis | Phase 2 | Status: COMPLETED